Company / Interest Expense per Share
ARDELYX, INC. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2023
5-year range
$0.02 / $0.05
FY2019-FY2023
Trend
-18.5%
vs FY2022
Sector context
#37 of 43
Health Care
What the data says
ARDELYX, INC.'s interest expense per share of $0.02 is lower than 86% of companies in the Health Care sector (FY2023). Interest Expense per Share has declined for 4 consecutive years, from $0.09 in FY2019 to $0.02 in FY2023.
Based on SEC 10-K filings.
0.02 in FY2023 with a 5-year CAGR of -22.1%.
Improved from $0.05 to $0.02 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -28.1%
- 5-Year CAGR
- -22.1%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 43This company $0.02 Sector average $18.61
▼
-99.9% below sector average
Key checks
Key Insights
- ARDELYX, INC.'s interest expense per share has declined for 4 consecutive years.
- In FY2023, interest expense per share decreased 18.5% year-over-year.
- Ranks #37 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.02 | -18.5% |
| FY2022 | $0.03 | -45.7% |
| FY2021 | $0.05 | -16.2% |
| FY2020 | $0.06 | -37.3% |
| FY2019 | $0.09 | +23.2% |
| FY2018 | $0.07 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026